arrow
A

Atsushi Tanaka

Saga University
H指数:35
被引数:5,124

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Comparative effectiveness of lipid-lowering therapies for primary cardiovascular prevention: a network meta-analysis of randomised controlled trials

比较降脂疗法在一级心血管预防中的有效性:一项随机对照试验的网络Meta分析

2026-10-280
OAAI
Sacubitril/valsartan and cardiac injury/stress and systemic inflammatory biomarkers in acute heart failure: a pre-specified secondary analysis of the PREMIER study

沙库巴曲/缬沙坦及心脏损伤/应激和全身性炎症生物标志物在急性心力衰竭中的作用:PREMIER研究的预先指定二次分析

2026-09-110
OAAI
Impact of estimated total blood volume on NT-proBNP response to angiotensin receptor-neprilysin inhibition in acute heart failure: Insights from the PREMIER study

估算总血容量对急性心力衰竭中血管紧张素受体-中性肽链内切酶抑制剂治疗下NT-proBNP反应的影响:来自PREMIER研究的见解

2026-08-010
PRE
Effects of finerenone on arterial stiffness and cardiorenal biomarkers in patients with type 2 diabetes and chronic kidney disease: a randomised placebo-controlled mechanistic trial (FIVE-STAR)

非奈利酮对动脉僵硬度及心肾生物标志物的影响:一项随机、安慰剂对照机制性试验(FIVE-STAR)

2025-12-050
OAAI
Qualitative and quantitative evaluation of microvascular obstruction with delayed enhancement cardiac computed tomography in patients with ST-segment elevation myocardial infarction

运用延迟增强心脏计算机断层扫描对ST段抬高型心肌梗死患者微血管梗阻进行定性与定量评估

2025-12-010
PRE
Impact of early in-hospital initiation of sacubitril/valsartan on left ventricular reverse remodelling in acute heart failure

早期院内沙库巴曲/缬沙坦启动对急性心力衰竭患者左心室逆转重构的影响

2025-08-012
OAAI
Impact of baseline left ventricular ejection fraction and body mass index on the effect of 24-week Ipragliflozin treatment on left ventricular diastolic function in patients with type 2 diabetes and chronic kidney disease: insights from the PROCEED trial

基线左心室射血分数和体重指数对24周伊普格列净治疗对2型糖尿病合并慢性肾病患者左心室舒张功能的影响:来自PROCEED试验的见解

2025-05-020
OA